Drug Companies Have A "Parasitic" Relationship With Journals
..."One author had claimed that a review was written by him but had made the mistake of leaving on Microsoft Words "track changes" facility in the document he sent, revealing that in fact everything had been ghost written with the help of the manufacturer of the drug. It carried the telltale note "marketing approval required please.""...
So much for their parroting of peer review bunk...
Chris Gupta
-----------------------BMJ 2005;330:9 (1 January), doi:10.1136/bmj.330.7481.9
Editor claims drug companies have a "parasitic" relationship with journals
London Lynn Eaton
The relationship between medical journals and the drug industry is "somewhere between symbiotic and parasitic," according to the editor of the Lancet, Richard Horton. But at the moment it has swung too much towards the parasitic, he told the House Commons select committee on health last month in his oral evidence on the role of the industry.
He outlined some of the financial incentives that could, potentially, influence a commercially run medical journal to publish a paper. Many of the formal research papers in the Lancet are reprinted and bought in bulk by drug companies, which use them for marketing purposes, he explained. The drug companies regularly try to exert pressure on the journal to run a paper by arguing that, if the journal does so, they will buy reprints, which will earn the journal more money, he said.
As another example of the parasitic nature of the relationship Dr Horton cited the example of a recently submitted paper on cyclo-oxygenase-2 inhibitors. When the journal raised questions with the authors over the paper, the drug company sponsoring the research called Dr Horton, asking him to "stop being so critical."
He reported to the committee that the company told him, "If you carry on like this we are going to pull the paper, and that means no income for the journal."
"That is just one example, and it is not that uncommon," he told the committee.
He outlined some of the measures that had been introduced across medical journals, including the BMJ, to try to reduce research fraud and to eliminate "ghost writing" of leading editorials. But he said this was based on people being honest.
"However, people do lie," he said.
One author had claimed that a review was written by him but had made the mistake of leaving on Microsoft Words "track changes" facility in the document he sent, revealing that in fact everything had been ghost written with the help of the manufacturer of the drug. It carried the telltale note "marketing approval required please." "The paper was rejected," said Mr Horton.
He also hit out at the way drugs were regulated in Britain and decried as "nonsense" the yellow card system for reporting adverse reactions.
"That is the worst possible way of doing epidemiology," he said. Instead what was needed was a five year periodic review of each drug at every stage on the market. "It would clear out the dross," he said.
Also giving evidence were Jenny Hope, medical correspondent at the Daily Mail, and Lois Rogers, medical editor at the Sunday Times. Ms Hope denied that drug companies unduly influenced her decisions about what made a news story.
"I dont feel I am being used, but I feel I am a target," she said. In deciding whether or not she pursued a story she said her decisions were based on whether the public should know about it, whether it was of interest, and whether it would be wrong to keep the information secret, she said.
Both she and Ms Rogers said they needed to know how the regulatory authority reached its decision in granting a licence to new products. At the moment this information is bound by a confidentiality agreement and is not made public in the United Kingdom. "The regulation process needs to be more transparent," said Ms Rogers.
The BMJ did not submit written evidence to the committees inquiry so was not invited to give oral evidence.
The transcript of the oral evidence is available here.
posted by Chris Gupta on Monday January 10 2005
updated on Saturday September 24 2005URL of this article:
http://www.newmediaexplorer.org/chris/2005/01/10/drug_companies_have_a_parasitic_relationship_with_journals.htm
Related ArticlesDemocracy At Work? - PPM On Fluoride
Here is a commentary on the recent (Jan, 25th, 2011) Public Participation Meeting (PPM) on Fluoride in the City of London, Ontario. The meeting started with a strong pro fluoride stance form the City engineer. His lack of knowledge on chemistry of the toxic wastes used to fluoridate water could embarrass even a high school student never mind his own profession. He blatantly violated his "duty to public welfare" as... [read more]
January 29, 2012 - Chris Gupta"Evidence Be Damned...Patient Outcome Is Irrelevant" - From Helke
Further to The Future of Complementary/Integrative Medicine & Patient Choice, here is an important must read and act note from Helke Ferrie, a superb Medical Science Writer and Publisher. Now that the true colours of the well known shortcomings of allopathic medicine are being discovered en mass, the screws are being tightened by the pharmaceutical masters on their medical puppets. It seems that they are prepared to stop at nothing.... [read more]
September 16, 2011 - Chris GuptaThe Future of Complementary/Integrative Medicine & Patient Choice
While this may appear like a Canadian issue only - it is not. There is a world wide push to force pharmaceutical and surgical based standard of care model via Draconian directives on all doctors. Any deviation will be subject to severe penalties. I am forwarding the following for your comment and action. Please note the Sept. 16th, 2011 deadline. Thanks, Chris Gupta http://tinyurl.com/6x9sbj2 --------------------- "Here is the College of... [read more]
September 13, 2011 - Chris Gupta
